Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs - 2Nexi expands alliance with PayPal
- 3Make your choice for a definitive Christmas getaway destination!
- 4Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
- 5Israel strikes south Lebanon after first direct talks in decades
- The Best Internet based Courses for Expertise Improvement
- He walked on the moon in 1972. This is his advice for the Artemis II astronauts.
- Artemis II astronauts say they're "ready to go" for moon launch
- Find the Lively Food Markets of South America
- Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- Multi-million-euro win in Spanish lottery in doubt due to oversight
- 2023's Best 10 Cell phone Advancements You Can't Miss
- Instructions to Expand Your Smash 1500's Presentation: Tips and Deceives
- Somaliland denies trading recognition with Israel for accepting Gazans
